David Shrayer

1.1k total citations · 1 hit paper
20 papers, 832 citations indexed

About

David Shrayer is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, David Shrayer has authored 20 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 9 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in David Shrayer's work include Immunotherapy and Immune Responses (13 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and vaccines and immunoinformatics approaches (3 papers). David Shrayer is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and vaccines and immunoinformatics approaches (3 papers). David Shrayer collaborates with scholars based in United States. David Shrayer's co-authors include Janet Butmarc, Vincent Falanga, Molly Chartier, Tatyana Yufit, Satori Iwamoto, Polly Carson, Harold J. Wanebo, Harm Hoekstra, Stefan O.P. Hofer and Jonathan S. Reichner and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Cancer.

In The Last Decade

David Shrayer

20 papers receiving 813 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Autologous Bone Marrow–Derived Cultured Mesenchymal Stem Cells Delivered in a Fibrin Spray Accelerate Healing in Murine and Human Cutaneous Wounds

2007 581 citations Vincent Falanga, Satori Iwamoto et al. Tissue Engineering profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Shrayer United States	9	412	362	204	167	164	20	832
Daisuke Inokuma Japan	10	590 1.4×	429 1.2×	220 1.1×	188 1.1×	224 1.4×	18	1.1k
Satori Iwamoto United States	8	413 1.0×	365 1.0×	201 1.0×	169 1.0×	169 1.0×	16	824
Eduardo Mansilla Argentina	13	427 1.0×	187 0.5×	203 1.0×	94 0.6×	198 1.2×	26	733
Tongzhu Sun China	13	260 0.6×	404 1.1×	163 0.8×	106 0.6×	214 1.3×	22	778
Lynne Wilson United States	7	250 0.6×	327 0.9×	109 0.5×	83 0.5×	173 1.1×	11	623
Carolina Caliári-Oliveira Brazil	11	462 1.1×	110 0.3×	243 1.2×	91 0.5×	210 1.3×	11	763
Weimin Deng China	9	443 1.1×	104 0.3×	191 0.9×	84 0.5×	271 1.7×	23	839
Christine Bousquet France	7	607 1.5×	75 0.2×	371 1.8×	148 0.9×	216 1.3×	11	849
Jianhua Gao China	17	542 1.3×	186 0.5×	492 2.4×	243 1.5×	160 1.0×	54	1.0k
Austin Nuschke United States	8	266 0.6×	228 0.6×	88 0.4×	109 0.7×	167 1.0×	8	571

Countries citing papers authored by David Shrayer

Since Specialization

Citations

This map shows the geographic impact of David Shrayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Shrayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Shrayer more than expected).

Fields of papers citing papers by David Shrayer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Shrayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Shrayer. The network helps show where David Shrayer may publish in the future.

Co-authorship network of co-authors of David Shrayer

This figure shows the co-authorship network connecting the top 25 collaborators of David Shrayer. A scholar is included among the top collaborators of David Shrayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Shrayer. David Shrayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shrayer, David, et al.. (2011). The effect of blocking the prosurvival AKT/P13K/mTOR and mutant KRAS–signaling pathways on chemotherapy resistance of pancreatic cancer.. Journal of Clinical Oncology. 29(15_suppl). e13514–e13514. 2 indexed citations

Cao, Cong, et al.. (2010). Abstract 221: C6-ceramide sensitizes the aggressive L3-6 pancreatic cancer cell line to paclitaxel-mediated antitumor effects in vivo and in vitro. Cancer Research. 70(8_Supplement). 221–221. 1 indexed citations

Falanga, Vincent, Satori Iwamoto, Molly Chartier, et al.. (2007). Autologous Bone Marrow–Derived Cultured Mesenchymal Stem Cells Delivered in a Fibrin Spray Accelerate Healing in Murine and Human Cutaneous Wounds. Tissue Engineering. 13(6). 1299–1312. 581 indexed citations breakdown →

Shrayer, David, et al.. (2004). Histologic Progression of B16 F10 Metastatic Melanoma in C57BL/6 Mice Over a Six Week Time Period: Distant Metastases before Local Growth. The Journal of Dermatology. 31(4). 299–304. 16 indexed citations

Shrayer, David, et al.. (2003). The effect of Taurolidine on adherent and floating subpopulations of melanoma cells. Anti-Cancer Drugs. 14(4). 295–303. 22 indexed citations

Shrayer, David, H A Bogaars, Bernard F. Cole, Stanley F. Wolf, & Harold J. Wanebo. (2002). Capacity of murine IL‐12 to inhibit the development of primary melanoma tumors and to prevent lung metastases in the melanoma‐challenged mice. PubMed. 2(2). 93–99. 5 indexed citations

Shrayer, David, et al.. (1999). Immunotherapy of mice with an irradiated melanoma vaccine coupled with interleukin-12. Clinical & Experimental Metastasis. 17(1). 73–80. 6 indexed citations

Hofer, Stefan O.P., David Shrayer, Jonathan S. Reichner, Harm Hoekstra, & Harold J. Wanebo. (1998). Wound-Induced Tumor Progression. Archives of Surgery. 133(4). 383–9. 115 indexed citations

Shrayer, David, et al.. (1998). Immunization of mice with melanoma cells transfected to secrete the superantigen, staphylococcal enterotoxin A. Cancer Immunology Immunotherapy. 46(1). 7–13. 8 indexed citations

10.

Shrayer, David, H A Bogaars, S F Wolf, Vincent J. Hearing, & Harold J. Wanebo. (1998). A new mouse model of experimental melanoma for vaccine and lymphokine therapy.. International Journal of Oncology. 13(2). 361–74. 9 indexed citations

11.

Shrayer, David, et al.. (1996). Intrasplenic vaccination against experimental melanoma. International Journal of Oncology. 9(1). 123–9. 1 indexed citations

12.

Shrayer, David, H A Bogaars, Vincent J. Hearing, & Harold J. Wanebo. (1996). Immunization of mice with irradiated melanoma tumor cells transfected to secrete lymphokines and coupled with IL-2 or GM-CSF therapy.. PubMed. 1(2). 126–33. 6 indexed citations

13.

Shrayer, David, et al.. (1995). Further characterization of a clinically relevant model of melanoma metastasis and an effective vaccine. Cancer Immunology Immunotherapy. 40(5). 277–282. 14 indexed citations

14.

Shrayer, David, et al.. (1994). Nude mouse model to study passive humoral immunotherapy directed against B16 F10 murine melanoma. Journal of Surgical Oncology. 57(1). 50–56. 3 indexed citations

15.

Shrayer, David, et al.. (1994). ANTITUMOR EFFECTS OF POLYVALENT AND MONOVALENT VACCINES COUPLED WITH INTERLEUKIN-2 IN A METASTATIC MELANOMA MODEL. International Journal of Oncology. 4(5). 1121–7. 6 indexed citations

16.

Hearing, Vincent J., Douglas M. Gersten, David Shrayer, & Lloyd W. Law. (1994). Novel Experimental Approaches to Melanoma Diagnosis and Therapy. The Journal of Dermatology. 21(11). 860–869. 4 indexed citations

17.

Shrayer, David, James Koness, Vincent J. Hearing, et al.. (1993). Preimmunization of mice with formalinized extracellular antigens of melanoma in combination with IL‐2 and surgical resection increased survival and tumor control in metastatic melanoma model. Journal of Surgical Oncology. 52(3). 142–149. 7 indexed citations

18.

Shrayer, David, et al.. (1993). Generation of cytotoxic antibodies to the B16 murine melanoma using a formalinized vaccine. International Journal of Cancer. 53(4). 696–702. 9 indexed citations

19.

Shrayer, David, Douglas M. Gersten, James Koness, et al.. (1992). B700 Antigen as a Component of an Antimelanoma Vaccine: Formalinized Extracellular Antigens. Pigment Cell Research. 5(3). 107–112. 8 indexed citations

20.

Shrayer, David, James Koness, Abby Maizel, & Harold J. Wanebo. (1992). Induction of interleukin-2, natural killer cell activity and anti-melanoma antibodies resulting from immunization of mice with formalinized extracellular antigens (FECA) of murine melanoma. Melanoma Research. 2(1). 47–56. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact